The lipoprotein complexing activity of glycosaminoglycans (GAG) prepared from human aortas with iipoprotein Lp(a) in comparison to low density lipoproteins (LDL) was determined tubidimetrically in the presence of Ca ++ . In control experiments, purified chondroitin-6 sulfate and proteoglycans (PG) were used. Lp(a) exhibited approximately a threefold higher reactivity. Analyzing the chemical composition of the complexes, we found that Lp(a) had greater than fourfold higher binding capacity for GAG. The binding capacity of Lp(a) to PG was 3.4-fold higher as compared to LDL. The binding capacity of both lipoproteins for chondroitin-6 sulfate was only 50% in comparison to GAG, but again Lp Its plasma concentration is under genetic control, and evidence is accumulating that a plasma level above 25 to 30 mg/dl must be considered as an independent risk factor for atherosclerosis and myocardial infarction. 234 Size, morphology, and lipid composition of Lp(a) is similar to low density lipoprotein (LDL). 5 The most striking difference between the two lipoproteins is the presence of an additional apolipoprotein (apo) in the Lp(a) particle. This protein is called apo a or Lp(a) specific antigen. Apo a may be dissociated from Lp(a) by treating with disulfide reducing agents, 6 leaving "Lp(a-)", a lipoprotein that is chemically and immunochemically similar to LDL Apo a exhibits a considerable size heterogeneity ranging from 300 to 700 kD. 7 The carbohydrate content, notably that of M. Bihari Varga and E. Gruber are at the Second Department of Pathology, Semmelweis Medical University, Budapest, Hungary. M. Rotheneder, R. Zechner, and G. M. Kostner are at the Medical Biochemistry Department, University of Graz, Graz, Austria.These studies were partly supported by Grant P 5891 from the Austrian Research Foundation.Address for correspondence: Professor Dr. G.M. Kostner, Medical Biochemistry Department, University of Graz, A-8010 Graz, Austria.Received November 12,1987; revision accepted July 18,1988. sialic acids of apo a, is considerably higher than that of apo B. To shed more light on the possible molecular mechanisms of atherogenicity, Lp(a) and LDL from the same donor were made to interact with GAG and proteoglycans (PG), and their capabilities to induce cholesteryl ester accumulation in mouse peritoneal macrophages (MPM), were compared. Major emphasis was given to lipoprotein-GAG complexes, because free GAG, but little PG, is found in circulating plasma.7 .
1011
Methods
Isolation and Characterization of LipoproteinsLDL and Lp(a) were prepared from pooled plasma of donors with Lp(a) levels of >40 mg/ld. In most cases, LDL and Lp(a) prepared from identical pools were compared. For a control, LDL was also prepared from individuals who were apparently Lp(a)-negative.